The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective

References

• Rojo-Martínez G, Valdés S, Soriguer F, et al. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@ bet. es study. Sci Rep. 2020;10(1):1–9. doi:10.1038/s41598-020-59643-7
   PubMedGoogle Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Valdes S, Rojo-Martínez G, Soriguer F. Evolution of prevalence of type 2 diabetes in adult Spanish population. Med Clin. 2007;129(9):352–355. doi:10.1157/13109554
   PubMed Web of Science ®Google Scholar
• Gómez-Peralta FME, Conde S, Conget I, Novials A, Novials A. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study. Endocrinología, Diabetes y Nutrición. 2021;68(9):642–653. doi:10.1016/j.endien.2021.11.020
   PubMed Web of Science ®Google Scholar
• Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care. 2005;28(1):78–83. doi:10.2337/diacare.28.1.78
   PubMed Web of Science ®Google Scholar
• Jude EB, Nixon M, O’Leary C, et al. Evaluating glycemic control in patients with type 2 diabetes suboptimally controlled on basal insulin: UK ATTAIN Real-World Study. Diab Ther. 2019;10(5):1847–1858. doi:10.1007/s13300-019-0667-6
   PubMed Web of Science ®Google Scholar
• Bailey TS, Stone JY, Stone JY. Emerging Technologies for Diabetes Care. Diabetes Technol Ther. 2018;20(S2):S2-78–S2-84. doi:10.1089/dia.2018.0115
   Google Scholar
• Robinson S, Newson RS, Liao B, Kennedy-Martin T, Battelino T. Missed and mistimed insulin doses in people with diabetes: a systematic literature review. Diabetes Technol Ther. 2021;23(12):844–856. doi:10.1089/dia.2021.0164
   PubMed Web of Science ®Google Scholar
• Mata-Cases M, Vlacho B, Real J, et al. Trends in the degree of control and treatment of cardiovascular risk factors in people with type 2 diabetes in a primary care setting in Catalonia during 2007–2018. Front Endocrinol. 2022;12:1884. doi:10.3389/fendo.2021.810757
   Web of Science ®Google Scholar
• Foster NC, Miller KM, Clements MA, et al. State of Type 1 diabetes management and outcomes from the T1D Exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72. doi:10.1089/dia.2018.0384
   PubMed Web of Science ®Google Scholar
• Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes audit and research in Tayside Scotland. Medicines monitoring unit. Lancet. 1997;350(9090):1505–1510. doi:10.1016/s0140-6736(97)06234-x
   PubMed Web of Science ®Google Scholar
• C JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224. doi:10.1111/dme.12651
   PubMed Web of Science ®Google Scholar
• Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger P-M. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study. Diab Med. 2012;29(5):682–689. doi:10.1111/j.1464-5491.2012.03605.x
   PubMed Web of Science ®Google Scholar
• Gregg EW, Hora I, Benoit SR. Resurgence in Diabetes-Related Complications. JAMA. 2019;321(19):1867–1868. doi:10.1001/jama.2019.3471
   PubMed Web of Science ®Google Scholar
• Gilbert TR, Blalock O, Polonsky WH, Polonsky WH. Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study. Diabetes Technol Ther. 2021;23(S1):S-35-S-39. doi:10.1089/dia.2020.0666
   PubMedGoogle Scholar
• Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care. 2010;33(2):240–245. doi:10.2337/dc09-1348
   PubMed Web of Science ®Google Scholar
• Skyler JS. Effects of glycemic control on diabetes complications and on the prevention of diabetes. Clin Diabetes. 2004;22(4):162–166. doi:10.2337/diaclin.22.4.162
   Google Scholar
• ISPOR Europe. Patient and health care professional experiences of suboptimal insulin dosing. Value in Health. Vienna, Austria; 2022.
   Google Scholar
• Brod MPB, Kongsø JH, Kongsø JH. Insulin administration and the impacts of forgetting a dose. Patient. 2014;7(1):63–71. doi:10.1007/s40271-013-0029-9
   PubMedGoogle Scholar
• Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol. 2001;57(4):457–478. doi:10.1002/jclp.1041
   PubMed Web of Science ®Google Scholar
• Beverly EA, Ritholz MD, Lee Y, et al. Look who’s (not) talking: diabetic patients’ willingness to discuss self-care with physicians. Diabetes Care. 2012;35(7):1466–1472. doi:10.2337/dc11-2422
   PubMed Web of Science ®Google Scholar
• Ampudia-Blasco FJ, Brod M, Brod M. A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients. Endocrinología y Nutrición. 2014;61(8):426–433. doi:10.1016/j.endonu.2014.03.008
   PubMedGoogle Scholar
• Fisher LPW, Hessler DM, Masharani U, et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabet Compl. 2015;29(4):572–577. doi:10.1016/j.jdiacomp.2015.01.012
   PubMed Web of Science ®Google Scholar
• Hessler DM, Fisher L, Polonsky WH, et al. Diabetes distress is linked with worsening diabetes management over time in adults with Type 1 diabetes. Diab Med. 2017;34(9):1228–1234. doi:10.1111/dme.13381
   PubMed Web of Science ®Google Scholar
• Psarou A, Cooper H, Wilding JPH. Patients’ Perspectives of oral and injectable type 2 diabetes medicines, their body weight and medicine-taking behavior in the UK: a systematic review and meta-ethnography. Diab Ther. 2018;9(5):1791–1810. doi:10.1007/s13300-018-0490-5
   PubMed Web of Science ®Google Scholar
• Stuckey HL, Vallis M, Kovacs Burns K, et al. “I do my best to listen to patients”: qualitative insights into DAWN2 (diabetes psychosocial care from the perspective of health care professionals in the second diabetes attitudes, wishes and needs study). Clin Ther. 2015;37(9):1986–98.e12. doi:10.1016/j.clinthera.2015.06.010
   PubMed Web of Science ®Google Scholar
• Conget IAE, Duque N, Díaz-Cerezo S, Rubio-de Santos M. Connected insulin systems in diabetes patients in Spain: present and future perspectives. Endocrinología, Diabetes y Nutrición. 2023;70(2):155–157. doi:10.1016/j.endinu.2022.10.006
   PubMed Web of Science ®Google Scholar
• Gomez-Peralta F, Abreu C. O035 Evaluation of the hypoglycaemia predictive algorithm in the insulclock insulin pen cap digital platform in type 1 diabetes treated with insulin multidose. Advan Technol Treat Diab. 2021;2021:1.
   Google Scholar
• Gomez-Peralta FAC, Gomez-Rodriguez S, Cruz-Bravo M, María-Sanchez C, Poza G, Ruiz-Valdepeñas L. Efficacy of insulclock in patients with poorly controlled type 1 diabetes mellitus: a pilot. Random Clin Trial. 2020;22(9):686–690. doi:10.1089/dia.2019.0427
   Google Scholar
• Secretaría General de Salud Digital. Estrategia de Salud Digital. Sistema Nacional de Salud; 2021:57–58.
   Google Scholar
• Pravettoni G, Triberti S. A “P5” approach to healthcare and health technology. P5 eHealth. 2020;2020:3–17.
   Google Scholar